MMED
MiniMed Group, Inc. Common Stock
NASDAQ: MMED · HEALTHCARE · HEALTH INFORMATION SERVICES
$11.68
-1.60% today
Updated 2026-05-05
Market cap
$3.40B
P/E ratio
—
P/S ratio
1.14x
EPS (TTM)
$-1.27
Dividend yield
—
52W range
$12 – $20
Volume
1.1M
MiniMed Group, Inc. Common Stock (MMED) Financial statements
SEC filings — annual and quarterly data.
Income statement — annual
| Item | 2023 | 2024 | 2025 |
|---|---|---|---|
| Revenue | $2.25B | $2.47B | $2.71B |
| Revenue growth (YoY) | — | +10.0% | +10.0% |
| Cost of revenue | $937.00M | $1.03B | $1.19B |
| Gross profit | $1.31B | $1.44B | $1.52B |
| Gross margin | 58.3% | 58.2% | 56.2% |
| R&D | $429.00M | $437.00M | $438.00M |
| SG&A | $960.00M | $1.06B | $1.13B |
| Operating income | $-69.00M | $-69.00M | $-202.00M |
| Operating margin | -3.1% | -2.8% | -7.4% |
| EBITDA | $46.00M | $60.00M | $107.00M |
| EBITDA margin | 2.0% | 2.4% | 3.9% |
| EBIT | $-69.00M | $-69.00M | $-36.00M |
| Interest expense | — | — | — |
| Income tax | — | — | — |
| Effective tax rate | 0.0% | 0.0% | 0.0% |
| Net income | $-96.00M | $-112.00M | $-250.00M |
| Net income growth (YoY) | — | -16.7% | -123.2% |
| Profit margin | -4.3% | -4.5% | -9.2% |